Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,899 public trials 2,122 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

NCT04543617

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Florida Cancer Specialists - Fort Myers (Broadway) Fort Myers, Florida, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
  • Great Lakes Cancer Center Williamsville, New York, United States
  • Instituto de Investigaciones Metabolicas (Idim) Buenos Aires, Argentina
View all 167 locations
View Trial Details
Active, not recruiting

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

NCT03333616

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

NCT04413123

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham & Woman's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UT Southwestern Medical Dallas, Texas, United States
View Trial Details
Active, not recruiting

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

NCT05911295

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Banner Gateway Medical Center Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCLA Hematology/Oncology - Alhambra Alhambra, California, United States
  • Foothill Cardioology Arcadia, California, United States
View all 268 locations
View Trial Details
Active, not recruiting

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

NCT02298959

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
Locations
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
View Trial Details
Active, not recruiting

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

NCT03485209

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSD Koman Family Outpatient Pavilion La Jolla, California, United States
View all 175 locations
View Trial Details

Related conditions